Insulin Injection

Product Details:

TIZARO (tirzepatide)  2.5 mg,  per 0.5 mL insulin, is a prescription medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose). It is not known if tizaro can be used in people who have had pancreatitis.ALSO KNOWN TO HELP WITH WEIGHT LOSS

Product Details:

Mounjaro 2.5mg Solution for Injection is a prescription medicine used to improve blood sugar control in adults with type 2 diabetes and support weight management in individuals who are overweight and those with obesity. It works by mimicking natural hormones to enhance insulin secretion and regulate appetite.

Mounjaro 2.5mg Solution for Injection is administered once weekly subcutaneously in the abdomen, thigh, or upper arm. To maximize its benefits, maintain a consistent injection schedule and complement treatment with a healthy diet and regular exercise. Follow your doctor’s instructions carefully, including any dose adjustments, and store the medication properly in the refrigerator.

Common side effects of Mounjaro 2.5mg Solution for Injection include nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are typically mild and improve over time. If they become severe or persistent, consult a doctor. They can help by adjusting the dose or suggesting ways to prevent them. Drinking plenty of water and staying hydrated may also help reduce discomfort from gastrointestinal symptoms.

Mounjaro 2.5mg Solution for Injection should not be used by individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2). Pregnant individuals or those planning to become pregnant should avoid this medicine as it may cause harmful effects on the developing baby. Before taking this medicine, inform your doctor about all the other medicines you are taking to avoid interaction.

Product Details:

Mounjaro 5mg Solution for Injection is a prescription medicine used to improve blood sugar control in adults with type 2 diabetes and support weight management in individuals who are overweight and those with obesity. It works by mimicking natural hormones to enhance insulin secretion and regulate appetite.

Mounjaro 5mg Solution for Injection is administered once weekly subcutaneously in the abdomen, thigh, or upper arm. To maximize its benefits, maintain a consistent injection schedule and complement treatment with a healthy diet and regular exercise. Follow your doctor’s instructions carefully, including any dose adjustments, and store the medication properly in the refrigerator.

Common side effects of Mounjaro 5mg Solution for Injection include nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are typically mild and improve over time. If they become severe or persistent, consult a doctor. They can help by adjusting the dose or suggesting ways to prevent them. Drinking plenty of water and staying hydrated may also help reduce discomfort from gastrointestinal symptoms.

Mounjaro 5mg Solution for Injection should not be used by individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2). Pregnant individuals or those planning to become pregnant should avoid this medicine as it may cause harmful effects on the developing baby. Before taking this medicine, inform your doctor about all the other medicines you are taking to avoid interaction.

Product Details:

Semaglutide is a GLP-1 analogue with 94% sequence as same as human GLP-1. Semaglutide acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP- receptor. GLP-1 is a physiological regulator of appetite and caloric intake. It is also present in several areas of brain that involved in appetite regulation. Semaglutide lowers body weight through decreased calorie intake and by an overall reduced appetite. It also stimulates insulin secretion and reduces glucagon secretion in a glucose dependent manner.

Product Details:

Semaglutide is a GLP-1 analogue with 94% sequence as same as human GLP-1. Semaglutide acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP- receptor. GLP-1 is a physiological regulator of appetite and caloric intake. It is also present in several areas of brain that involved in appetite regulation. Semaglutide lowers body weight through decreased calorie intake and by an overall reduced appetite. It also stimulates insulin secretion and reduces glucagon secretion in a glucose dependent manner

Product Details:

Semaglutide is a GLP-1 analogue with 94% sequence as same as human GLP-1. Semaglutide acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP- receptor. GLP-1 is a physiological regulator of appetite and caloric intake. It is also present in several areas of brain that involved in appetite regulation. Semaglutide lowers body weight through decreased calorie intake and by an overall reduced appetite. It also stimulates insulin secretion and reduces glucagon secretion in a glucose dependent manner.

Product Details:

Semaglutide is a GLP-1 analogue with 94% sequence as same as human GLP-1. Semaglutide acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP- receptor. GLP-1 is a physiological regulator of appetite and caloric intake. It is also present in several areas of brain that involved in appetite regulation. Semaglutide lowers body weight through decreased calorie intake and by an overall reduced appetite. It also stimulates insulin secretion and reduces glucagon secretion in a glucose dependent manner.